Palestine · Delayed Price · Currency is JOD · Price in USD Jerusalem Pharmaceuticals Statistics
Total Valuation
PEX:JPH has a market cap or net worth of JOD 91.83 million. The enterprise value is 85.82 million.
| Market Cap | 91.83M |
| Enterprise Value | 85.82M |
Important Dates
The next estimated earnings date is Wednesday, November 11, 2026.
| Earnings Date | Nov 11, 2026 |
| Ex-Dividend Date | Apr 16, 2026 |
Share Statistics
PEX:JPH has 36.00 million shares outstanding. The number of shares has increased by 0.33% in one year.
| Current Share Class | 36.00M |
| Shares Outstanding | 36.00M |
| Shares Change (YoY) | +0.33% |
| Shares Change (QoQ) | +0.03% |
| Owned by Insiders (%) | 42.30% |
| Owned by Institutions (%) | 6.39% |
| Float | 13.79M |
Valuation Ratios
The trailing PE ratio is 13.15.
| PE Ratio | 13.15 |
| Forward PE | n/a |
| PS Ratio | 2.52 |
| PB Ratio | 1.39 |
| P/TBV Ratio | 1.47 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 12.25 |
| EV / Sales | 2.36 |
| EV / EBITDA | 7.53 |
| EV / EBIT | 8.58 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.41, with a Debt / Equity ratio of 0.02.
| Current Ratio | 3.41 |
| Quick Ratio | 2.58 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.10 |
| Debt / FCF | -0.59 |
| Interest Coverage | 579.17 |
Financial Efficiency
Return on equity (ROE) is 11.64% and return on invested capital (ROIC) is 13.58%.
| Return on Equity (ROE) | 11.64% |
| Return on Assets (ROA) | 7.91% |
| Return on Invested Capital (ROIC) | 13.58% |
| Return on Capital Employed (ROCE) | 14.02% |
| Weighted Average Cost of Capital (WACC) | 6.52% |
| Revenue Per Employee | 61,202 |
| Profits Per Employee | 11,773 |
| Employee Count | 595 |
| Asset Turnover | 0.46 |
| Inventory Turnover | 1.75 |
Taxes
In the past 12 months, PEX:JPH has paid 1.87 million in taxes.
| Income Tax | 1.87M |
| Effective Tax Rate | 20.90% |
Stock Price Statistics
The stock price has increased by +73.49% in the last 52 weeks. The beta is 0.43, so PEX:JPH's price volatility has been lower than the market average.
| Beta (5Y) | 0.43 |
| 52-Week Price Change | +73.49% |
| 50-Day Moving Average | 3.71 |
| 200-Day Moving Average | 2.51 |
| Relative Strength Index (RSI) | 48.25 |
| Average Volume (20 Days) | 1,703 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, PEX:JPH had revenue of JOD 36.42 million and earned 7.00 million in profits. Earnings per share was 0.19.
| Revenue | 36.42M |
| Gross Profit | 21.37M |
| Operating Income | 10.00M |
| Pretax Income | 8.95M |
| Net Income | 7.00M |
| EBITDA | 11.17M |
| EBIT | 10.00M |
| Earnings Per Share (EPS) | 0.19 |
Balance Sheet
The company has 7.98 million in cash and 1.13 million in debt, with a net cash position of 6.84 million or 0.19 per share.
| Cash & Cash Equivalents | 7.98M |
| Total Debt | 1.13M |
| Net Cash | 6.84M |
| Net Cash Per Share | 0.19 |
| Equity (Book Value) | 65.86M |
| Book Value Per Share | 1.81 |
| Working Capital | 34.85M |
Cash Flow
In the last 12 months, operating cash flow was -785,373 and capital expenditures -1.15 million, giving a free cash flow of -1.93 million.
| Operating Cash Flow | -785,373 |
| Capital Expenditures | -1.15M |
| Depreciation & Amortization | 1.17M |
| Net Borrowing | -75,354 |
| Free Cash Flow | -1.93M |
| FCF Per Share | -0.05 |
Margins
Gross margin is 58.69%, with operating and profit margins of 27.47% and 19.24%.
| Gross Margin | 58.69% |
| Operating Margin | 27.47% |
| Pretax Margin | 24.57% |
| Profit Margin | 19.24% |
| EBITDA Margin | 30.69% |
| EBIT Margin | 27.47% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.05, which amounts to a dividend yield of 2.08%.
| Dividend Per Share | 0.05 |
| Dividend Yield | 2.08% |
| Dividend Growth (YoY) | 275.00% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 22.79% |
| Buyback Yield | -0.33% |
| Shareholder Yield | 1.82% |
| Earnings Yield | 7.63% |
| FCF Yield | -2.10% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on April 16, 2026. It was a forward split with a ratio of 2.
| Last Split Date | Apr 16, 2026 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |